We are live on ! Find out more
SK

Sarah Ketterer Causeway Capital Management

AUM $9.24B
1-Year Est. Return 21.27%
 

Sarah Ketterer is co-founder and CEO of Causeway Capital Management, a firm specializing in international and global value equities. Causeway is known for disciplined valuation work across developed and emerging markets. Ketterer’s commentary is often sought for perspective on non-U.S. equities, currencies, and relative value abroad.

This Fund
S&P 500
This Quarter Est. Return
+1.09%
1 Year Est. Return
+21.27%
3 Year Est. Return
+72.78%
5 Year Est. Return
+71.25%
10 Year Est. Return
+497.07%
AUM
$2.88B
AUM Growth
+$433M
Cap. Flow
+$217M
Cap. Flow %
7.51%
Top 10 Hldgs %
42.19%
Holding
80
New
5
Increased
36
Reduced
25
Closed
6

Top Buys

Rank Stock Value
1
CVX icon
Chevron
CVX
+$87.7M
2
LLY icon
Eli Lilly
LLY
+$84.7M
3
SNX icon
TD Synnex
SNX
+$69.4M
4
MAT icon
Mattel
MAT
+$61.3M
5
HSBC icon
HSBC
HSBC
+$45M

Sector Composition

Rank Sector Weight
1 Financials 19.16%
2 Technology 18.59%
3 Healthcare 15.52%
4 Industrials 12.11%
5 Energy 8.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RDS.A
76
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
-111,620
Closed -$8.53M
APC
77
DELISTED
Anadarko Petroleum
APC
-690,174
Closed -$78.4M

Similar funds

Sarah Ketterer's Q3 2014 Portfolio in Review

As of Q3 2014, Sarah Ketterer held 80 positions worth $2.88B, up 18% from $2.45B the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Sarah Ketterer deployed $217M of net new capital in Q3 2014, opening 5 new positions and adding to 36 existing holdings. Its largest new stake was Chevron: 687,278 shares worth $89.3M.

By sector, the portfolio is most concentrated in Financials at 19% of assets, down from 22% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was UnitedHealth, an estimated $31M trimmed.

  • Sarah Ketterer's largest Q3 2014 buy was Chevron: 687,278 shares worth $89.3M.
  • Sarah Ketterer added most to Mattel in Q3 2014, an estimated $61.3M increase.
  • Sarah Ketterer's biggest Q3 2014 reduction was UnitedHealth, cutting an estimated $31M.
  • Sarah Ketterer fully exited Anadarko Petroleum in Q3 2014, selling an estimated $78.4M.
  • Sarah Ketterer's ten largest holdings make up 42% of its $2.88B portfolio in Q3 2014.
  • Sarah Ketterer opened 5 new positions and closed 6 in Q3 2014.
  • Sarah Ketterer's portfolio value rose 18% quarter-over-quarter to $2.88B.

Based on Causeway Capital Management's 13F filing for Q3 2014, filed 13 Nov 2014.